Department of Biological Information, Graduate School of Bioscience and Biotechnology, Tokyo Institute of Technology, 4259 Midori-ku, Nagatsuta, Yokohama 226-8501, Japan.
J Biochem. 2009 Nov;146(5):713-23. doi: 10.1093/jb/mvp117. Epub 2009 Jul 24.
Periostin is a matricellular protein participating in the tissue remodelling of damaged cardiac tissue after acute myocardial infarction and of the periodontal ligament in mice. However, further studies on the periostin protein have been limited by the intrinsic difficulty of purifying this protein produced in Escherichia coli due to its insolubility. Here, we demonstrate the expression of recombinant periostin protein with high solubility and monodispersity in E. coli. Periostin is composed of an amino-terminal EMI domain, a tandem repeat of 4 fas1 domains (RD1-4), and a carboxyl-terminal region (CTR). We expressed the RD4-CTR region tagged with GST at amino-terminal and 6x Histidine at carboxyl-terminal end in E. coli. The recombinant protein was purified by using GSH-Sepharose and nickel chelation affinity chromatography, followed by gel filtration chromatography. The RD4-CTR protein exhibited high solubility and monodispersity. On average, 9.1 mg of purified RD4-CTR was routinely obtained from 1 L of culture media. Furthermore, the RD4-CTR was biochemically active, because it bound to the RD1-4, the same as intact periostin protein that had been purified from mammalian cells. Our results should enable us to produce the periostin recombinant protein in large quantities and facilitate future studies on functional and structural analyses of periostin.
骨膜蛋白是一种基质细胞蛋白,参与急性心肌梗死后受损心肌组织和小鼠牙周韧带的组织重塑。然而,由于大肠杆菌中内源性骨膜蛋白难以纯化,进一步的骨膜蛋白研究受到限制。在这里,我们证明了在大肠杆菌中表达具有高可溶性和单分散性的重组骨膜蛋白。骨膜蛋白由氨基末端 EMI 结构域、4 个 fas1 结构域(RD1-4)的串联重复和羧基末端区域(CTR)组成。我们在氨基末端标记 GST,在羧基末端标记 6xHis,在大肠杆菌中表达 RD4-CTR 区域。重组蛋白通过 GSH-Sepharose 和镍螯合亲和层析进行纯化,然后通过凝胶过滤层析进行纯化。RD4-CTR 蛋白表现出高可溶性和单分散性。平均而言,从 1L 培养基中可常规获得 9.1mg 纯化的 RD4-CTR。此外,RD4-CTR 具有生物化学活性,因为它与 RD1-4 结合,与从哺乳动物细胞中纯化的完整骨膜蛋白相同。我们的结果应该能够使我们大量生产骨膜蛋白重组蛋白,并促进骨膜蛋白功能和结构分析的未来研究。